Read + Share
Zhao S, Zhang M, Zhang Q, Wu J, et al. Anlotinib alone or in combination with bevacizumab in the treatment of recurrent
high-grade glioma: a prospective single-arm, open-label phase II trial. BMC Cancer 2024;24:6.
PMID: 38166698
|
 |
|
Zhao S, Zhang M, Zhang Q, Wu J, et al. Anlotinib alone or in combination with bevacizumab in the treatment of recurrent
high-grade glioma: a prospective single-arm, open-label phase II trial. BMC Cancer 2024;24:6.
PMID: 38166698
|
|
|
|